508 related articles for article (PubMed ID: 23060457)
1. Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.
Wang Y; Ye L; Wang X; Li J; Song L; Ho W
Innate Immun; 2013; 19(2):193-202. PubMed ID: 23060457
[TBL] [Abstract][Full Text] [Related]
2. Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes.
Wang Y; Li J; Wang X; Ye L; Zhou Y; Ho W
J Viral Hepat; 2013 Jun; 20(6):385-94. PubMed ID: 23647955
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line.
Wang Y; Li J; Wang X; Ye L; Zhou Y; Thomas RM; Ho W
Innate Immun; 2014 Jan; 20(1):3-11. PubMed ID: 23529855
[TBL] [Abstract][Full Text] [Related]
4. Induction of interferon-λ contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells.
Zhou L; Li JL; Zhou Y; Liu JB; Zhuang K; Gao JF; Liu S; Sang M; Wu JG; Ho WZ
Mol Hum Reprod; 2015 Dec; 21(12):917-29. PubMed ID: 26502803
[TBL] [Abstract][Full Text] [Related]
5. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
[TBL] [Abstract][Full Text] [Related]
6. Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes.
Brownell J; Wagoner J; Lovelace ES; Thirstrup D; Mohar I; Smith W; Giugliano S; Li K; Crispe IN; Rosen HR; Polyak SJ
J Hepatol; 2013 Oct; 59(4):701-8. PubMed ID: 23770038
[TBL] [Abstract][Full Text] [Related]
7. TLR3 Activation of Hepatic Stellate Cell Line Suppresses HBV Replication in HepG2 Cells.
Zhang B; Liu Y; Wang X; Li J; Xu X; Guo L; Ho WZ
Front Immunol; 2018; 9():2921. PubMed ID: 30619284
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 3 and RIG-I-like receptor activation induces innate antiviral responses in mouse ovarian granulosa cells.
Yan K; Zhu W; Yu L; Li N; Zhang X; Liu P; Chen Q; Chen Y; Han D
Mol Cell Endocrinol; 2013 Jun; 372(1-2):73-85. PubMed ID: 23567548
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection induces the beta interferon signaling pathway in immortalized human hepatocytes.
Kanda T; Steele R; Ray R; Ray RB
J Virol; 2007 Nov; 81(22):12375-81. PubMed ID: 17804510
[TBL] [Abstract][Full Text] [Related]
10. IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection.
Park H; Serti E; Eke O; Muchmore B; Prokunina-Olsson L; Capone S; Folgori A; Rehermann B
Hepatology; 2012 Dec; 56(6):2060-70. PubMed ID: 22706965
[TBL] [Abstract][Full Text] [Related]
11. Immune activation of human brain microvascular endothelial cells inhibits HIV replication in macrophages.
Li J; Wang Y; Wang X; Ye L; Zhou Y; Persidsky Y; Ho W
Blood; 2013 Apr; 121(15):2934-42. PubMed ID: 23401273
[TBL] [Abstract][Full Text] [Related]
12. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.
Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD
Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176
[TBL] [Abstract][Full Text] [Related]
13. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
14. HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.
Israelow B; Narbus CM; Sourisseau M; Evans MJ
Hepatology; 2014 Oct; 60(4):1170-9. PubMed ID: 24833036
[TBL] [Abstract][Full Text] [Related]
15. Expression of an IRF-3 fusion protein and mouse estrogen receptor, inhibits hepatitis C viral replication in RIG-I-deficient Huh 7.5 cells.
Yao L; Yan X; Dong H; Nelson DR; Liu C; Li X
Virol J; 2011 Sep; 8():445. PubMed ID: 21936899
[TBL] [Abstract][Full Text] [Related]
16. (-)-Epigallocatechin-3-Gallate Enhances Hepatitis C Virus Double-Stranded RNA Intermediates-Triggered Innate Immune Responses in Hepatocytes.
Wang Y; Li J; Wang X; Peña JC; Li K; Zhang T; Ho W
Sci Rep; 2016 Feb; 6():21595. PubMed ID: 26879672
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication.
Wang B; Trippler M; Pei R; Lu M; Broering R; Gerken G; Schlaak JF
J Hepatol; 2009 Dec; 51(6):1037-45. PubMed ID: 19716616
[TBL] [Abstract][Full Text] [Related]
18. Hepatic stellate cells, liver innate immunity, and hepatitis C virus.
Wang Y; Li J; Wang X; Sang M; Ho W
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1(0 1):112-5. PubMed ID: 23855305
[TBL] [Abstract][Full Text] [Related]
19. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
[TBL] [Abstract][Full Text] [Related]
20. Rhinovirus and dsRNA induce RIG-I-like receptors and expression of interferon β and λ1 in human bronchial smooth muscle cells.
Calvén J; Yudina Y; Uller L
PLoS One; 2013; 8(4):e62718. PubMed ID: 23658644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
